As we predicted, a significant decrease in the frequency of the 7 repeat genotype was observed in the FM patients (w 2 ¼ 29.91, P ¼ 0.008, 14 df) ( Table 1 , Part a). Note that the two most common genotypes are the 4/4 repeat followed by the 4/7 repeat as has been observed in most Caucasian populations. No difference in the frequency of the 7 repeat was observed in the control group when grouped by ethnicity (data not shown: likelihood ratio ¼ 2.39, P ¼ 0.302 comparing Ashkenazi Jews, non-Ashkenazi Jews and Bedouin). When the genotype was collapsed into subjects with at least one 7 repeat vs 'all others' (no 7 repeat) the frequency of the 7 repeat was significantly reduced (39.5 vs 27.2%) in the FM subjects (data not shown: Women suffering from FM show an unusual personality profile compared to control subjects. It makes sense, therefore, that provisional associations between genes associated with personality traits in nonselected populations will show stronger associations in an extreme phenotypic group such as FM. The current study strengthens this notion. We observed a decreased representation of the DRD4 7 repeat in a small group of FM patients characterized by unusually low scores on NS as measured by a self-report personality inventory, the TPQ. Moreover, an association was also observed between TPQ NS scores and the 7 repeat only in the FM group: subjects with the 7 repeat had significantly higher scores than subjects without this repeat, but nevertheless significantly lower than the control group. Altogether, recent evidence including the current investigation suggests an involvement of both serotonergic 2,3 as well as dopaminergic 8 neurotransmitter pathways in FM likely mediated by personality traits.
Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders SIR-Reports of abnormal glucose metabolism in patients with mood and psychotic disorders predate modern psychopharmacology, suggesting a role in these disorders independent of medication effects. 1 Surprisingly little is known, however, about cellular brain glucose metabolism in these disorders. We investigated the polyol (or 'sorbitol') pathway of glucose metabolism, because it is involved in nervous tissue disease in diabetes mellitus. 2 We previously reported elevated concentrations of sorbitol-the initial polyol pathway metabolite of glucose-in the cerebrospinal fluid of nondiabetic patients with bipolar disorder and unipolar major depression.
Using a gas chromatography-mass spectrometry (GC-MS) method with stable isotope internal standards, 3 we measured concentrations of sorbitol and its polyol pathway metabolite, fructose, as well as myoinositol, a polyol glucose metabolite that is not synthesized by the polyol pathway, in 60 blocks of post-mortem, parietal lobe (Brodmann area
Manual, 4th edition (DSM-IV) by two senior psychiatrists using medical records and family interviews. Normal controls were determined free of psychiatric illness or treatment after post-mortem interview with a first-degree relative. Groups did not differ significantly on demographic or tissue variables, including age (overall mean of 45.4 years), race, gender, brain pH, and post-mortem interval (PMI). Analyses of tissue characteristics and clinical and demographic information have been published. 4 To remove the confound of diabetes mellitus, we excluded data from three brains (two schizophrenic and one bipolar) from our analyses due to a premortem diagnosis of diabetes mellitus. All statistical analyses in this study were two-tailed and performed using SPSS 8.0. Figure 1 is a box and whisker plot of the data distribution for each brain group. The median (interquartile range) sorbitol concentrations in nmol/g wet tissue were: bipolar disorder, 94(200); schizophrenia, 94(206); nonpsychotic unipolar depression, 114 (79); and normal controls, 45 (39). As noted in Figure 1 , sorbitol concentrations of all three psychiatric groups significantly exceeded those of controls. In comparison, fructose, whose concentration as a polyol pathway metabolite only partially accounts for its total concentration, showed a trend-level increase in the three psychiatric groups (w 2 ¼ 3.7, df ¼ 3, P ¼ 0.29). Myoinositol, a non-polyol pathway metabolite, was similar across groups (w 2 ¼ 0.36, df ¼ 3, P ¼ 0.95). To control for possibly confounding agonal and postmortem effects on glucose metabolism, data were log 10 transformed and analyzed by analysis of covariance with brain pH and PMI as covariates. Means differed significantly (F ¼ 3.9, df ¼ 3, P ¼ 0.013), with adjusted means of the three psychiatric groups exceeding controls by Bryant-Paulson post hoc test (Po0.05). Sorbitol concentration did not appear to be influenced by psychotropic medication use as assessed by correlation with lifetime fluphenazine equivalents or comparison across brains grouped by medication type.
Next, we used Spearman's rank-correlation coefficient (r), to assess the relationship between sorbitol concentration and the levels of eight proteins previously reported to be increased or decreased compared to controls in dorsolateral prefrontal cortex of the same set of brains. 5 After Bonferroni correction of alpha to Po0.007, we found significant correlations with two proteins: the glycolytic enzyme, fructose-1, 6-bisphophatase (aldolase c) (r ¼ 0.375, P ¼ 0.004) and an isoform of the specific astrocyte marker, glial fibrillary acid protein (GFAP) (r ¼ À0.456, Po0.001). Both proteins are either exclusively or predominantly expressed by astrocytes. 6 These correlations along with previous reports of polyol pathway metabolism in astrocytes, 7 suggest that brain sorbitol concentration derives from glucose flux through the astrocyte polyol pathway. Positive correlation with aldolase c expression was also observed for fructose (r ¼ 0.385, Po0.003), and is consistent with the role of aldolase c in fructose metabolism downstream from the polyol pathway. 8 Negative correlation with GFAP expression is consistent with a recent report of increased polyol pathway activity causing a profound decrease in retinal astrocyte GFAP expression in diabetic rat. 9 Although in need of replication, we believe that these findings suggest a disturbance of brain glucose metabolism in mood and psychotic disorders. Finding increased brain sorbitol concentration across all three psychiatric groups could, however, suggest the influence of a confound that is more prevalent among the psychiatric groups. Therefore, we performed further post hoc analyses to assess the possible effects of cigarette smoking for which we had data on 39 of Group sorbitol concentrations differed significantly by Kruskall-Wallis ANOVA (w 2 ¼ 12.7, df ¼ 3, P ¼ 0.005), with all three psychiatric groups exceeding controls by Dunnett's post hoc test (Po0.05). Three brains (two schizophrenic and one bipolar) from the 60-brain set were removed from the analysis due to premortem diagnosis of diabetes mellitus.
